These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37236832)

  • 21. Pre-biopsy 3-Tesla MRI and targeted biopsy of the index prostate cancer: correlation with robot-assisted radical prostatectomy.
    Patel U; Dasgupta P; Challacombe B; Cahill D; Brown C; Patel R; Kirby R
    BJU Int; 2017 Jan; 119(1):82-90. PubMed ID: 27153933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance Imaging.
    Ploussard G; Beauval JB; Lesourd M; Almeras C; Assoun J; Aziza R; Gautier JR; Loison G; Portalez D; Salin A; Tollon C; Soulié M; Malavaud B; Roumiguié M
    J Urol; 2019 Dec; 202(6):1182-1187. PubMed ID: 31246548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis.
    Schoots IG; Nieboer D; Giganti F; Moore CM; Bangma CH; Roobol MJ
    BJU Int; 2018 Dec; 122(6):946-958. PubMed ID: 29679430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined Systematic and MRI-US Fusion Prostate Biopsy Has the Highest Grading Accuracy When Compared to Final Pathology.
    Andras I; Cata ED; Serban A; Kadula P; Telecan T; Buzoianu M; Bungardean M; Stanca DV; Coman I; Crisan N
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34067302
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostate cancer detection with magnetic resonance imaging (MRI)/ cognitive fusion biopsy: Comparing standard and targeted prostate biopsy with final prostatectomy histology.
    Ryan J; Broe MP; Moran D; Mulvin D; Heffernan E; Swan N; Moran DE
    Can Urol Assoc J; 2021 Sep; 15(9):E483-E487. PubMed ID: 33591900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging target fusion biopsy vs. transrectal ultrasound-guided biopsy - A comparative study of ISUP score upgrading risk in the final radical prostatectomy specimen.
    Guimarães T; Gil M; Medeiros M; Andrade V; Guerra J; Pinheiro H; Fernandes F; Pina J; Lopes Dias J; Campos Pinheiro L
    Arch Ital Urol Androl; 2022 Sep; 94(3):278-284. PubMed ID: 36165470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiologist-like artificial intelligence for grade group prediction of radical prostatectomy for reducing upgrading and downgrading from biopsy.
    Shao L; Yan Y; Liu Z; Ye X; Xia H; Zhu X; Zhang Y; Zhang Z; Chen H; He W; Liu C; Lu M; Huang Y; Ma L; Sun K; Zhou X; Yang G; Lu J; Tian J
    Theranostics; 2020; 10(22):10200-10212. PubMed ID: 32929343
    [No Abstract]   [Full Text] [Related]  

  • 28. Prostate Cancers Detected by Magnetic Resonance Imaging-Targeted Biopsies Have a Higher Percentage of Gleason Pattern 4 Component and Are Less Likely to Be Upgraded in Radical Prostatectomies.
    Zhao Y; Deng FM; Huang H; Lee P; Lepor H; Rosenkrantz AB; Taneja S; Melamed J; Zhou M
    Arch Pathol Lab Med; 2019 Jan; 143(1):86-91. PubMed ID: 29965785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR; McNeal JE; Gill H; Presti JC
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy.
    Liu H; Tang K; Xia D; Peng E; Wang L; Chen Z
    Pathol Res Pract; 2020 Nov; 216(11):153235. PubMed ID: 33035728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system.
    Alqahtani S; Wei C; Zhang Y; Szewczyk-Bieda M; Wilson J; Huang Z; Nabi G
    Sci Rep; 2020 May; 10(1):7722. PubMed ID: 32382097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological features of Prostate Imaging Reporting and Data System (PI-RADS) 3 MRI lesions in biopsy and radical prostatectomy specimens.
    Rahota RG; Diamand R; Malavaud B; Fiard G; Descotes JL; Peltier A; Beauval JB; Roumeguère T; Roumiguié M; Albisinni S; Ploussard G
    BJU Int; 2022 May; 129(5):621-626. PubMed ID: 34358405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative upgrading of prostate cancer in men ≥75 years: a propensity score-matched analysis.
    Herlemann A; Buchner A; Kretschmer A; Apfelbeck M; Stief CG; Gratzke C; Tritschler S
    World J Urol; 2017 Oct; 35(10):1517-1524. PubMed ID: 28493044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling.
    Luzzago S; Petralia G; Maresca D; Sabatini I; Cordima G; Brescia A; Verweij F; Garelli G; Mistretta FA; Cioffi A; Pricolo P; Alessi S; Ferro M; Matei DV; Renne G; de Cobelli O; Musi G
    Urol Oncol; 2020 Dec; 38(12):929.e11-929.e19. PubMed ID: 32600928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer.
    Ranasinghe W; Reichard CA; Nyame YA; Sundi D; Tosoian JJ; Wilkins L; Alam R; Achim MF; Wang X; Stephenson AJ; Klein EA; Ross AE; Allaf ME; Davis JW; Chapin BF
    J Urol; 2020 Oct; 204(4):748-753. PubMed ID: 32259468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores.
    Garmer M; Busch M; Mateiescu S; Fahlbusch DE; Wagener B; Grönemeyer DH
    Acad Radiol; 2015 Nov; 22(11):1409-18. PubMed ID: 26343218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downgrading of biopsy based Gleason score in prostatectomy specimens.
    Treurniet KM; Trudel D; Sykes J; Evans AJ; Finelli A; Van der Kwast TH
    J Clin Pathol; 2014 Apr; 67(4):313-8. PubMed ID: 24403214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era?
    Mazzone E; Stabile A; Sorce G; Pellegrino F; Barletta F; Motterle G; Scuderi S; Cirulli GO; Cucchiara V; Brembilla G; Esposito A; Gandaglia G; Fossati N; De Cobelli F; Montorsi F; Karnes RJ; Guccini I; Briganti A
    Urol Oncol; 2021 Nov; 39(11):784.e1-784.e9. PubMed ID: 33865687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer grade downgrading at time of prostatectomy provides risk-stratification insight into future tumor behavior after prostatectomy.
    Wang S; Ryan Russell J; Drescher M; Park A; Legesse T; Kundra V; Tran PT; Phelan M; Naslund M; Minhaj Siddiqui M
    Prostate; 2022 Dec; 82(16):1520-1528. PubMed ID: 35923127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate.
    Costa DN; Goldberg K; Leon AD; Lotan Y; Xi Y; Aziz M; Freifeld Y; Margulis V; Raj G; Roehrborn CG; Hornberger B; Desai N; Bagrodia A; Francis F; Pedrosa I; Cadeddu JA
    Eur Urol Oncol; 2019 Jul; 2(4):397-404. PubMed ID: 31277776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.